Hui-Ming Wang - Publications
Affiliations: | 1987-1988 | University of Iowa, Iowa City, IA |
Year | Citation | Score | |||
---|---|---|---|---|---|
1998 | Kato M, Wang H, Kainulainen V, Fitzgerald ML, Ledbetter S, Ornitz DM, Bernfield M. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nature Medicine. 4: 691-7. PMID 9623978 DOI: 10.1038/Nm0698-691 | 0.347 | |||
1997 | Wang H, Toida T, Kim YS, Capila I, Hileman RE, Bernfield M, Linhardt RJ. Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. Biochemical and Biophysical Research Communications. 235: 369-73. PMID 9199199 DOI: 10.1006/Bbrc.1997.6789 | 0.404 | |||
1993 | Desai UR, Wang HM, Kelly TR, Linhardt RJ. Structure elucidation of a novel acidic tetrasaccharide and hexasaccharide derived from a chemically modified heparin. Carbohydrate Research. 241: 249-59. PMID 8472255 DOI: 10.1016/0008-6215(93)80112-R | 0.433 | |||
1993 | Desai UR, Wang H, Ampofo SA, Linhardt RJ. Oligosaccharide composition of heparin and low-molecular-weight heparins by capillary electrophoresis Analytical Biochemistry. 213: 120-127. PMID 8238864 DOI: 10.1006/Abio.1993.1394 | 0.438 | |||
1993 | Desai UR, Wang H, Linhardt RJ. Substrate specificity of the heparin lyases from Flavobacterium heparinum Archives of Biochemistry and Biophysics. 306: 461-468. PMID 8215450 DOI: 10.1006/Abbi.1993.1538 | 0.4 | |||
1992 | Linhardt RJ, Wang HM, Ampofo SA. New methodologies in heparin structure analysis and the generation of LMW heparins. Advances in Experimental Medicine and Biology. 313: 37-47. PMID 1332444 DOI: 10.1007/978-1-4899-2444-5_4 | 0.45 | |||
Show low-probability matches. |